Citizen Portal
Sign In

Caswell County to stay in NCHIP; board approves 6% renewal and considers excluding GLP‑1 weight‑loss drugs

Caswell County Board of Commissioners · February 16, 2026

Loading...

AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

After a presentation by NCHIP, the Caswell County Board voted to remain in the North Carolina Health Insurance Pool and authorized a renewal that includes a recommended 6% rate increase; NCHIP proposed removing GLP‑1 weight‑loss drugs from plan coverage and offered subsidized direct‑to‑manufacturer options for affected employees.

The Caswell County Board of Commissioners voted Feb. 16 to remain a member of the North Carolina Health Insurance Pool (NCHIP) and to proceed with a recommended 6% renewal in funding rates for the county’s group health plan.

David Costa, representing NCHIP, told commissioners the pool has grown to 39 members and now covers about 12,000 employees and 17,000 covered lives. He said pharmacy claims are the principal headwind for this renewal cycle and highlighted a 23% year‑over‑year increase in Caswell County pharmacy claims, driven largely by GLP‑1 drugs used for weight‑loss. “What we’re saying is we need to remove the GLP‑1 specifically for weight loss,” Costa said, explaining that most employers do not cover those drugs and that excluding them would reduce the county’s projected increase to 6% rather than the larger increases seen elsewhere.

Costa said the pool maintains roughly $20 million in reserves and described an alternative for employees who currently receive GLP‑1 drugs: a third‑party program that steers members to direct‑to‑manufacturer purchases and allows an employer subsidy. He noted that the retail cost to the county when covered on the plan is about $1,000 per prescription per month, while direct purchase from manufacturers can be closer to $350–$400 per month; NCHIP’s recommended plan design assumes excluding GLP‑1 weight‑loss drugs but allows the board two months to decide on possible subsidy approaches.

Commissioners asked about health risks if coverage were discontinued for current users, and Costa said members could still fill valid prescriptions through their providers but would no longer have those costs paid by the county plan. Commissioners also discussed whether a partial subsidy or deductible changes could limit employee out‑of‑pocket costs; Costa said those options could reduce the net increase, citing sample subsidy scenarios.

After discussion, a motion to remain with NCHIP and continue the county plan under the recommended design carried on a voice vote. The board did not record an itemized roll‑call tally in the public session.

Next steps: the board must finalize plan‑design decisions (including whether to adopt any subsidy program or change deductibles) before the renewal deadline cited by NCHIP.